Search

everythinglearnresearchcommunity

for

Search:↓

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Adalimumab may cause severe hair loss in some patients.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Baricitinib is effective as a treatment for severe hair loss.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Dutasteride may help reduce brain inflammation and improve cognition.